Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
07/2003
07/31/2003WO2002012286A3 Stress proteins and peptides and methods of use thereof
07/31/2003WO2001034566A3 Protease inhibitors
07/31/2003US20030144525 Conjugated aromatic compounds with a pyridine substituent
07/31/2003US20030144347 Method for treating autoimmune disease
07/31/2003US20030144300 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
07/31/2003US20030144293 N-alkyl-adamantyl triazinyl benzamide derivatives
07/31/2003US20030144288 Sulfur compounds such as 4-fluoro-N-(4-methoxy-7-(tetrahydro-pyran-4-yl)-benzothiazol-2-yl) -benzamide, used as preferential adenosine receptor ligands for the prophylaxis of neurodegenerative disorders
07/31/2003US20030144279 5-Heterocyclo-pyrazoles
07/31/2003US20030144267 Novel compounds
07/31/2003US20030144262 Heteroaryl and heterocyclic nitrogen ring containing hydrazide compounds useful for treating neurodegenerative disorderes
07/31/2003US20030144253 Useful for treating or preventing neuronal damage associated with neurological diseases
07/31/2003US20030144203 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/31/2003US20030143626 Such as cyclin-dependent kinases and/or bax genes/proteins covalently linked to platform compound (thioredoxin); drug screening
07/31/2003US20030143589 Drug metabolizing enzymes
07/31/2003US20030143271 For therapy and prophylaxis of cyclooxygenase-2 mediated disorder and for providing cardioprotection
07/31/2003US20030143246 Ganoderma lucidum spores for treatment of autoimmune diseases
07/31/2003US20030143209 For gene therapy of cancers or cardiovascular conditions
07/31/2003US20030143207 Remodeling of tissues and organ
07/31/2003US20030143192 Chemokine beta-7
07/31/2003CA2476773A1 Monoclonal antibodies against extracellular loops of c5ar
07/31/2003CA2474292A1 Sustained release pharmaceutical composition
07/31/2003CA2473796A1 Substituted quinazolin-4-ylamine analogues
07/31/2003CA2473781A1 Glycoisoforms of adiponectin and uses thereof
07/31/2003CA2473490A1 Peptide-carrying bodies for immune response
07/31/2003CA2473395A1 Phospholipid bodies and use thereof in medical treatment
07/31/2003CA2471740A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies
07/31/2003CA2471342A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
07/30/2003EP1330467A2 Modified, hydroxy-substituted aromatic structures having cytoprotective activity
07/30/2003EP1330436A1 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3-3 receptor antagonists
07/30/2003EP1330428A1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride
07/30/2003EP1330268A1 Targeted therapeutic agents
07/30/2003EP1178787B1 Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof
07/30/2003CN1433417A Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
07/30/2003CN1433411A Chemical compounds
07/30/2003CN1433408A Aminothiazole inhibitors of cyslin dependent kinases
07/30/2003CN1432577A Sheep growth hormone releasing hormone gene and its expression product and application
07/29/2003US6599901 Pyridone substituted benzothiazole derivatives
07/24/2003WO2003060085A2 Mammalian neural stem cells, compositions and uses thereof
07/24/2003WO2003060082A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
07/24/2003WO2003059952A1 Bispecific antibody dna constructs for intramuscular administration
07/24/2003WO2003059950A1 Ifnar2 mutants, their production and use
07/24/2003WO2003059893A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
07/24/2003WO2003059891A1 Substituted pyridazinones as inhibitors of p38
07/24/2003WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
07/24/2003WO2003059323A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii
07/24/2003WO2003059294A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
07/24/2003WO2003059293A2 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators
07/24/2003WO2003059276A2 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
07/24/2003WO2003059269A2 Acridone inhibitors of impdh enzyme
07/24/2003WO2003059264A2 Methods for the induction of professional and cytokine-producing regulatory cells
07/24/2003WO2003047577A3 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
07/24/2003WO2003032918A3 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors
07/24/2003WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction
07/24/2003US20030140360 Transgenic mammals and reagents for improving long-term memory
07/24/2003US20030140356 Mimetic of functional transforming growth factor/myostatin (MSTN 350); for increasing/inhibiting muscle growth in animals; veterinary medicine; antiproliferative/anticarcinogeneic agents
07/24/2003US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors
07/24/2003US20030139574 Active hedgehog protein conjugate
07/24/2003US20030139453 Difluorobutyric acid metalloprotease inhibitors
07/24/2003US20030139452 Pyrazole-derived kinase inhibitors and uses thereof
07/24/2003US20030139447 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
07/24/2003US20030139435 N-heterocyclic inhibitors of TNF-alpha expression
07/24/2003US20030139410 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
07/24/2003US20030139407 Efficient synthesis of 5-heteroatom-containing -pyrazoles
07/24/2003US20030139384 Transdermal supplying testosterone
07/24/2003US20030139355 Medicine for orthopaedic surgical application and a treating method using thereof
07/24/2003US20030138931 Hydrolase polypeptide for dephosphorylating mitogen activated kinases (MAP-kinase); antiapoptosis; antiproliferative agents
07/24/2003US20030138772 Polymerase chain reactions to screen and isolate parvovirus DNA obtained from tissue and/or cells without coinfection by helper viruses; gene therapy
07/24/2003US20030138422 Antibodies against growth and differentiation factor-8 (GDF-8), also known as myostatin, including fragments; muscle and bone degenerative disorders; muscular dystropy/atrophy; antidiabetic agents; congestive obstructive pulmonary disease
07/24/2003CA2474239A1 Substituted pyridazinones as inhibitors of p38
07/24/2003CA2474141A1 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
07/24/2003CA2474002A1 Bispecific antibody dna constructs for intramuscular administration
07/24/2003CA2473893A1 Stable salts of o-acetylsalicylic acid with basic amino acids ii
07/24/2003CA2472204A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
07/24/2003CA2472168A1 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
07/24/2003CA2469800A1 Methods for the induction of professional and cytokine-producing regulatory cells
07/23/2003EP1329223A1 Expression potentiator for protein synthesis regulatory gene
07/23/2003EP1329222A1 Isoflavone compositions for use in medicine
07/23/2003EP1328653A2 Highly expressible genes
07/23/2003EP1328634A2 Genes expressed in the cell cycle
07/23/2003EP1328624A2 B7-like molecules and uses thereof
07/23/2003EP1328525A2 2,3,4,5-tetrahydro-1h-[1,4]diazepino[1,7-a]indole compounds
07/23/2003EP1328514A1 Amide derivatives as nmda receptor antagonists
07/23/2003EP1328271A2 Method for the treatment of neurological and neuropsychological disorders
07/23/2003EP1328270A2 Method for the treatment of neurological and neuropsychological disorders
07/23/2003EP1235573B1 Combination of riluzole and gabapentin and use thereof for the treatment of motor neuron disorders
07/23/2003CN1432024A Immunodominant acetylcholine receptor alpha subunit peptides
07/23/2003CN1432011A Benzoamide piperidine compounds as substance P antagonists
07/23/2003CN1431904A Protease inhitors
07/23/2003CN1431003A Medicine for curing cerebral concussion and injuries from falls
07/23/2003CN1115342C Hypnotic beta-carboline derivatives, process for their prepn. and their use as medicinal products
07/22/2003US6596746 Cyclic protein tyrosine kinase inhibitors
07/22/2003US6596745 Method for treating fibrotic diseases with azolium chroman compounds
07/22/2003US6596738 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I):
07/22/2003US6596731 Substituted imidazo[1,2-A] pyridine derivatives
07/22/2003US6596730 Phenyl urea and phenyl thiourea derivatives
07/22/2003US6596718 7-Morpholin-4yl-benzothiazole amide derivatives
07/22/2003US6596711 GABA B receptor agonists for use in the treatment of CNS disorders, such as muscle relaxation in spinal spasticity, cardiovascular disorders, asthma, gut motility disorders such as irritable bowel syndrome and gastroesophogeal reflux
07/22/2003US6596709 6-sulphanoyl-3-quinolylphosphonic acid compounds
07/21/2003CA2416791A1 A receptor-ligand pairing for immune response
07/21/2003CA2368656A1 Receptor-ligand pairing for anti-inflammatory response
1 ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 ... 233